Science Explorer Interactive view Map
Company · Tokyo · Japan

Bayer (Japan)

bayer.jp/english/index.htmlROR OpenAlex
World rank, all time
#33,161
of 42,892
Rank in Japan
#1,386
of 2,112
Research works
148
▲ 36% vs 2013–17
Citations
3.7k
25.1 per fractional work
Top-10% rate
16.0%
record average 16.5%
Open access
46%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.58× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.43× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.59× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.29× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.19× its world share, 0 worksChemistryComputer Science: 0.20× its world share, 0 worksComputer ScienceEngineering: 0.31× its world share, 1 worksEngineeringMaterials Science: 0.60× its world share, 0 worksMaterials ScienceMedicine: 3.83× its world share, 13 worksMedicineNursing: 3.66× its world share, 0 worksNursingBusiness, Management and Accounting: 0.58× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.36× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

Which keywords describe research at Bayer (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Macular Degeneration, Cardiovascular Disease, Epidemiology, Diabetic Retinopathy, Chronic Kidney Disease and Vascular Endothelial Growth Factor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation21▲ 6.0×32 topics
  2. Epidemiology11▲ 1.84×39 topics
  3. Cancer8▲ 4.0×17 topics
  4. Cardiovascular Disease7▲ 4.2×11 topics
  5. Oxidative Stress7▲ 2.6×20 topics
  6. Quality of Life6▲ 2.8×11 topics
  7. Macular Degeneration5▲ 28×3 topics
  8. Diabetic Retinopathy5▲ 41×2 topics
  9. Chronic Kidney Disease5▲ 13×6 topics
  10. Clinical Trials5▲ 5.1×6 topics
  11. Vascular Endothelial Growth Factor5▲ 32×3 topics
  12. Choroidal Thickness4▲ 60×1 topic
  13. Retinal Pigment Epithelium4▲ 60×1 topic
  14. Angiogenesis4▲ 7.0×9 topics
  15. Heart Failure4▲ 6.3×8 topics
  16. Clinical Guidelines4▲ 8.9×6 topics
  17. Neuroprotection4▲ 7.4×6 topics
  18. Immunotherapy4▲ 4.0×7 topics
  19. Biomarkers4▲ 4.1×10 topics
  20. Cancer Treatment4▲ 9.4×4 topics
  21. Tumor Microenvironment4▲ 7.0×7 topics
  22. Genetic Mutations4▲ 4.6×6 topics
  23. Guidelines4▲ 5.0×4 topics
  24. Prostate Cancer4▲ 16×3 topics
  25. Anticoagulant Therapy3▲ 19×2 topics
  26. Immunity3▲ 6.5×4 topics
  27. Prophylaxis3▲ 16×2 topics
  28. Hormone Therapy3▲ 20×3 topics
  29. Catheter Ablation3▲ 17×2 topics
  30. Hemostasis3▲ 14×4 topics
  31. Recombinant Factor VIIa3▲ 50×2 topics
  32. Genomic Profiling3▲ 20×2 topics
  33. Anemia3▲ 17×4 topics
  34. Gene Therapy3▲ 7.5×4 topics
  35. Stroke3▲ 12×5 topics
  36. Immune Responses3▲ 19×2 topics
  37. Signaling3▲ 17×4 topics
  38. Stroke Prevention3▲ 14×2 topics
  39. Atrial Fibrillation3▲ 19×1 topic
  40. Risk Stratification3▲ 27×1 topic

Which research topics does Bayer (Japan) publish most on?

By volume in 2022–2025: Prostate Cancer Treatment and Research, Retinal Diseases and Treatments, Blood Coagulation and Thrombosis Mechanisms and Hemophilia Treatment and Research.

Prostate Cancer Treatmen…1Prostate Cancer Treatment and Research: 1 fractional worksRetinal Diseases and Tre…1Retinal Diseases and Treatments: 1 fractional worksBlood Coagulation and Th…1Blood Coagulation and Thrombosis Mechanisms: 1 fractional worksHemophilia Treatment and…1Hemophilia Treatment and Research: 1 fractional worksOcular Diseases and Behçet’s Syndrome: 1 fractional worksRetinal and Optic Conditions: 0 fractional worksMenstrual Health and Dis…0Menstrual Health and Disorders: 0 fractional worksDialysis and Renal Disea…0Dialysis and Renal Disease Management: 0 fractional worksMyeloproliferative Neopl…0Myeloproliferative Neoplasms: Diagnosis and Treatment: 0 fractional worksAdvanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional works
Pulmonary and Respiratory MedicineOphthalmologyHematologyPublic Health, Environmental and Occupational Health2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  2. 2 Retinal Diseases and Treatments Ophthalmology 1 works
  3. 3 Blood Coagulation and Thrombosis Mechanisms Hematology 1 works
  4. 4 Hemophilia Treatment and Research Hematology 1 works
  5. 5 Ocular Diseases and Behçet’s Syndrome Ophthalmology 1 works
  6. 6 Retinal and Optic Conditions Ophthalmology 0 works
  7. 7 Menstrual Health and Disorders Public Health, Environmental and Occupational Health 0 works
  8. 8 Dialysis and Renal Disease Management Nephrology 0 works
  9. 9 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  10. 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.5%not open53.5%

World: 28% of research is openly available.

with international co-authors36.9%domestic only63.1%

World: 19% is written across borders.

How has Bayer (Japan)'s research output changed?

Output in 2018–2022 was 36% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.